137TiP A phase III study of alpelisib and fulvestrant for...

Annals of Oncology 2016 / 12 Vol. 27; Iss. suppl_9

137TiP A phase III study of alpelisib and fulvestrant for hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2–) advanced breast cancer (ABC) progressing on or after aromatase inhibitor (AI) therapy (SOLAR-1)

Iwata, H., Rubovszky, G., Loibl, S., Ciruelos, E., Campone, M., Juric, D., Rugo, H., Mayer, I., Conte, P.F., Kaufman, B., Inoue, K., Tesch, H., Li, Y-S., Mingorance, I.D., Ryvo, L., Iwase, H., Longin,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
27
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw577.020
Date:
December, 2016
File:
PDF, 55 KB
english, 2016
Conversion to is in progress
Conversion to is failed